Skip to main content
OpenTrials
Completed

NCT Number: NCT03261050

Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders

Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. The investigators want to test whether the treatment actually changes those two mechanisms using brain scan data, which is more objective than completing questionnaires and even interviews.

In the first phase of the study (R61), the investigators will compare women in the treatment versus those on a wait-list. If the investigators can show that the treatment "works" (does what the investigators think it does) compared to no active treatment (women will be allowed to seek and receive outside help but investigators will not provide it until after the wait-list), investigators will conduct the second phase of study (R33),where they will randomly assign women with an ED to either the new treatment or to a group treatment that represents what many college mental health clinics provide to their clients with ED.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–34 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University, Stanford, California, United States

Loading trial locations.

About this study

Only 3-20% of individuals with eating disorders (EDs) receive treatment, and those who do rarely receive evidence-based treatments because they are very intensive and costly, few clinicians deliver them, and they differ for the various EDs. These factors have hindered broad implementation of evidence-based treatments, implying that a brief frontline outpatient treatment for a range of EDs that could be easily, cheaply, and widely implemented would address a major public health problem. There is also limited experimental evidence regarding factors that maintain EDs and mechanisms of action for ED treatments. The investigators propose to conduct a project that translates basic persuasion research into clinical hypotheses and a novel treatment.

The investigators hypothesize that EDs are maintained by (1) excessive valuation of the thin beauty ideal, which prompts caloric restriction and other unhealthy weight control behaviors (vomiting, laxative use, excessive exercise) that increase binge eating risk, and (2) excessive valuation of high-calorie foods, which maintains binge eating. The investigators propose to evaluate a treatment that addresses these hypothesized maintenance processes. Two pilot trials evaluated a novel 8-session group dissonance-based treatment (Counter Attitudinal Therapy; CAT) wherein women with any ED appropriate for outpatient care completed activities in which they collectively discuss costs of pursuing the thin ideal and the ED behaviors in which they personally engage (unhealthy weight control behaviors and binge eating), which putatively creates dissonance about engaging in those particular behaviors that reduce valuation of the thin ideal and high-calorie binge foods.

During the COVID-19 shelter-at-home orders taking place at both research sites, the investigators will not measure in-person only outcomes including fMRI, ECG, computerized implicit associated tests, and height and weight measurements for all participants that have assessments during this order. The investigators will continue to conduct treatment groups that will be administered on a virtual platform.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • DSM-5 eating disorder
  • Must have a primary care doctor

Exclusion criteria

  • Non-English speakers
  • BMI <75% ideal body weight
  • Current acute suicidal ideation (defined as thoughts of a specific method or plan)
  • Comorbid psychiatric disorder that would disrupt groups (e.g., bipolar disorder, substance misuse)
  • Serious medical problems (e.g., diabetes)

Treatment and study plan

Counter Attitudinal Therapy

Behavioral

8 weekly 60 minute sessions of dissonance-based treatment wherein women with any eating disorder complete verbal, written, and behavioral activities.

Interpersonal Therapy

Behavioral

8 weekly 60 minute sessions of interpersonal-based treatment wherein women with an eating disorder complete verbal, written, and behavioral activities.

Primary outcomes

  1. Change in occurrences of binge eating episodes using Eating Disorder Diagnostic Interview

    Time frame: Week 8; R33 also reviews at 6-month follow-up

    Interviewer assesses frequency in binge eating episodes

  2. Change in occurrences of compensatory weight control behavior using Eating Disorder Diagnostic Interview

    Time frame: Week 8; R33 also reviews at 6-month follow-up

    Interviewer assesses frequency of compensatory weight control behaviors

  3. Change in psychosocial impairment due to eating disorder symptoms using the Clinical Impairment Assessment Questionnaire

    Time frame: Week 8; R33 also reviews at 6-month follow-up

    Interviewer assesses change in psychosocial impairment

Secondary outcomes

  1. Change in reward region of the brain using fMRI

    Time frame: Week 1 and Week 8

    Assess if CAT produces larger pre-post reductions in reward region in response to thin models and binge food (Not collected during COVID-19 shelter-at-home order)

  2. Change in suicidal ideation/attempts using the Patient Health Questionnaire version 9 (PHQ-9)

    Time frame: Weeks 2, 4 and 6

    Assess if there are any changes in suicide ideation/attempts

  3. Change in negative affect using the Positive Affect and Negative Affect Scale-Revised

    Time frame: Weeks 2, 4, and 6

    Assess if there are any changes in negative affect

  4. Change in body dissatisfaction using the Body Dissatisfaction Scale

    Time frame: Weeks 2, 4 and 6

    Assess if there are any changes in body dissatisfaction

  5. Change in food addiction using the Yale Food Addiction Scale version 2.0

    Time frame: Weeks 2, 4, and 6

    Assess if there are any changes in food addiction (Only collected during R61 phase)

  6. Change in valuation of thin ideal using the Thin Ideal Valuation Scale

    Time frame: Weeks 2, 4, 6, and 8; R33 also reviews at 6-month follow-up

    Assess if there are any changes in valuation of the thin beauty ideal

  7. Change in dietary restraint using the 10-item Dutch Restrained Eating Scale

    Time frame: Week 8; R33 also reviews at 6-month follow-up

    Assess if there are any changes in dietary restraint

  8. Change in implicit associations of binge foods, thin models, and eating disorder behavior words

    Time frame: Week 8; R33 also reviews at 6-month follow-up

    Three implicit association tasks will assess response to binge foods, thin models, and eating disorder behavior words at pre- and post-test (Not collected during COVID-19 shelter-at-home order)

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Important dates

Study start
2017
Primary completion
2025
Study completion
2025
First posted
Aug 24, 2017
Registry last updated
Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.